Experimental and Therapeutic Medicine · 2020 · 20 citations · 34 references
Life SciencesImmunologyPharmacologyCell SignalingInflammationInnate ImmunityInflammatory Cell SignalingInflammatory ProcessesInflammatory SignalingMacrophage BiologyMetabolic InflammationToll-like ReceptorsCholesterol EffluxLow-density Lipoprotein ParticlesNf-κb SignalingNuclear Factor Kappa B ActivationNuclear Factor Kappa B InhibitionToll-like Receptor SignalingToll-like Receptors In InflammationWestern Blot Analysis
cultured THP-1 cells were induced to become macrophages using phorbol-12-myristate-13-acetate. The cells were then pre-treated with curcumin before inducing the foam cell model by addition of oxidized low-density lipoprotein (ox-LDL). Western blot assays were used to detect expression levels of toll-like receptor (TLR)4, nuclear factor κB (NF-κB), NF-κB inhibitor α (IκBα), phosphorylated-IκBα and ATP binding cassette transporter (ABC)A1. Reverse transcription-quantitative PCR was employed to examine mRNA levels of TLR4, microRNA (miR)33a and ABCA1. ELISAs were used to detect inflammatory factors, including tumor necrosis factor (TNF)-α, monocyte chemotactic protein (MCP)-1 and interleukin (IL)-6. ox-LDL successfully induced the foam cell model, promoted phosphorylation of IκBα, promoted nuclear translocation of NF-κB, promoted the expression of TLR4 and miR33a, and promoted the secretion of TNF-α, MCP-1 and Il-6. Additionally, ox-LDL reduced the expression of ABCA1 and cholesterol efflux. However, pretreatment with curcumin increased the expression of ABCA1 and cholesterol efflux and suppressed secretion of TNF-α, MCP-1 and Il-6. TLR4 antibodies, the NF-κB blocker, PDTC, and the miR33a inhibitor also reduced the abnormal transformations induced by ox-LDL. Curcumin promoted cholesterol efflux by suppressing the TLR4/NF-κB/miR33a signaling pathway, and reduced the formation of foam cells and the secretion of inflammatory factors.
34
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Heart Disease and Stroke Statistics—2008 Update
Wayne D. Rosamond, Katherine M. Flegal, Karen L. Furie et al. · Circulation · 2007 · 3.7K citations
Medicine, Cardiology, Health Policy +17
Executive Summary: Heart Disease and Stroke Statistics—2012 Update
Véronique L. Roger, Alan S. Go, Donald M. Lloyd‐Jones et al. · Circulation · 2012 · 1.5K citations · Full text